Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
BDSX on Nasdaq
There are no Buy or Sell transactions made by Matthew Strobeck since 12/11/2024
Holdings reported by Matthew Strobeck for Biodesix Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2.61M |
$3.64M |
$1.40 |
Nov 5, 2024 |
By Birchview Fund LLC |
|
|
| Common Stock |
2.54M |
$3.46M |
$1.36 |
Nov 5, 2024 |
Direct |
|
|
| Common Stock |
119K |
$162K |
$1.36 |
Nov 5, 2024 |
By UTMA Account |
|
|
| Common Stock |
89.7K |
$125K |
$1.40 |
Nov 5, 2024 |
By Birchview Capital Separately Managed Account |
|
|
| Common Stock |
40.7K |
$55.3K |
$1.36 |
Nov 5, 2024 |
By Clajer Capital LLC |
|
|
| Restricted Stock Units |
80.5K |
$22.6K |
$0.42 |
May 20, 2025 |
Direct |
Common Stock |
|
| Stock Options (Right to Buy) |
42K |
|
|
May 20, 2025 |
Direct |
Common Stock |
|
| Stock Options (Right to Buy) |
37.1K |
|
|
May 21, 2024 |
Direct |
Common Stock |
|
| Series A Non-Voting Convertible Preferred Stock |
0 |
|
|
May 23, 2024 |
By Birchview Capital Separately Managed Account |
Common Stock |
|
| Series A Non-Voting Convertible Preferred Stock |
0 |
|
|
May 23, 2024 |
By Birchview Fund LLC |
Common Stock |
|
Transactions reported by Matthew Strobeck for Biodesix Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.